СПИСОК ЛИТЕРАТУРЫ.
Аруин Л.И., Капуллер Л.Л. Исаков В.А. Морфологическая диагностика болезней желудка и кишечника// М.: «Триада-Х», 1998. -с. 483-496.
1. Аруин Л.И. Значение биопсий при язвенной болезни// арх. Патологии, 1989 - Т.51, №7. - с. 70-76.
2. Аруин Л.И. Новая классификация гастрита// Рос. журн. гастроэнтерол., гепатол. и колопроктол. 1997. Т.ТШ. N3. с. 82-85.
3. Анашкин В. А., Перлин Д. В., Хасабов Н. Н., Яковенко А. В., Яковенко Э.П., Обуховский Б. И. Состояние верхних отделов пищеварительного тракта и распространенность Helicobacter pylori инфекции у больных после трансплантации почки// "Нефрология и диализ", Т. 5, 2003 г., №4.
4. Барановский А. Ю., Кондрашина Е.А., Назаренко Л.И. Диетология: Руководство. 4-е изд. /Под ред. А.Ю.Барановского - СПб.: Питер, 2012.- с.1024.
5. Голофеевский В.Ю. Введение в клиническую морфологию желудка и двенадцатиперстной кишки// СПБ. Фолиант, 2005 год - с.6-15.
6. Григорьева Н.Д. Диетическая коррекция метаболических нарушений у больных, получающих лечение хроническим гемодиализом: Автореф. дис. канд. мед. наук: 14.00.05. / СПбГМУ- Санкт-Петербург, 1999 - с.18.
7. Дружинин П.В., Новиков Л.Ф., Лысиков Ю.А. Основы нутрициологии. Концепция рационального и сбалансированного питания (часть 1) // НИИ Питания РАМН. - 2010 - с.120.
8. Луфт В. М., Хорошилов И. Е. Нутриционная поддержка больных в клинической практике// ВмедА, СПб. - 1997- с.120.
9. Мартиросов Э.Г. Методы определения и оценки физического развития // Спортивная медицина и лечебная физкультура / Под
ред. А.И. Журавлевой, Н.Д. Граевской. - М.: Медицина, 1993 - с.117-138.
10. Матюшечкин Е.В., Шишкин А.Н., Серебряная Н.Б., Кареев В.Е., Тимоховская Г.Ю. Цитокиновый статус и клинико-морфологические особенности гастродуоденальной зоны у больных, получающих заместительную почечную терапию // Нефрология 2007; 11 (4): с.64-69.
11. Милованов Ю.С. Нутритивный статус у больных ХБП на додиализном этапе// Вестник научно-технического развития, ФППО (В) ММА им. И.М. Сеченова - 2010.- №3(31), с.11-23.
12. Петрова Н.Н., Яковенко И.А. Качество жизни больных при лечении хронической почечной недостаточности методом гемодиализа // Сборник материалов рабочего совещания нефрологов Северо-Запада России. 16 мая 1996 г., Санкт-Петербург, Россия - СПб.- 1996.- с. 83 - 85.
13. Райхельсон К.Л. Влияние нутриционного статуса и гастродуоденальной патологии на прогноз и течение терминальной стадии хронической почечной недостаточности при применении активных методов лечения (гемодиализ, перитонеальный диализ, трансплантация почек): Автореф. дис. канд. мед. наук.- 14.00.05. / МАПО СПб.- Санкт-Петербург, 1999.- с.24.
14. Рудман Д. Оценка состояния питания // Внутренние болезни /Браунвальд
Е., Иссельбах К.Дж., Петерсдорф Р.Г.(Пер. с англ., в 10 кн.).- М.: Медицина- 1993.-Кн. 2.- с. 379.
15. Румянцев А.Ш., Коростелева Н.Ю. Влияние физических тренировок на белковый катаболизм при терапии гемодиализом // Нефрология- 1998.-Т. 2, № 2. - с. 80-83.
16. Рысс Е.С., Рябов С.И., Лутошкин М.Б., Панина И.Ю. Пищеварительная система // Лечение хронической почечной недостаточности / Под ред. С.И. Рябова. - СПб.: Фолиант- 1997. - с. 11-25.
17. Самсонов В.А. Язвенная болезнь. Новые материалы к патоморфологии основных ее форм. - Петрозаводск: Карелия -1975. - с.261.
18. Хорошилов И.Е., Панов П.Б., под ред. А.В. Шаброва. Клиническая нутрициология // Учеб.пособие, ЭЛБИ-СПб. - 2009- с.284.
19. Шакурова Н. Р. Особенности патоморфоза слизистой оболочки желудка и луковицы двенадцатиперстной кишки при Helicobacter pylori - ассоциированной язвенной болезни с различными вариантами клинического течения. Автореф. дис. канд. мед. наук.- 14.00.05 - внутренние болезни 03.00.25 - гистология, цитология, клеточная биология/ ГОУ ВПО Сибирский государственный медицинский университет Росздрава.- Томск- 2009. - с.3.
20. Шептулин А.А., Инфекция Helicobacter pylori и рак желудка: современное состояние проблемы. Российский журнал гастроэнтерологии, гепатологии, колопроктологии - 2012.- с. 77-82.
21. Шилова Е.М., Козловской Л.В. Коррекция нутритивных нарушений у больных хронической болезнью почек на додиализном этапе// Учебное пособие, Издательский дом «Русский врач», Москва. - 2009 -с. 4-13.
22. Шостка Г. Д., Долгодворов А. Ф., Команденко М. С. Показания к началу гемодиализной терапии у больных с хронической почечной недостаточностью // Нефрология.-1999.-Т. 3, № 1.-с. 14-19.
23. Яковенко А.А., Асанина Ю.Ю., Кучер А.Г., Бовкун И.В., Румянцев А.Ш., Вадюхина М.В. Особенности патогенеза недостаточности питания у больных с хронической почечной недостаточностью, получающих лечение хроническим гемодиализом// Нефрология - 2008. Т. 12. № 3. с. 56-65..
24. Яковенко А.А., Кучер А.Г., Румянцев А.Ш. Значение интерлейкина-6 в патогенезе «уремической недостаточности питания» у пациентов с терминальной почечной недостаточностью, получающих лечение хроническим гемодиализом //Нефрология - 2010. Т. 14. № 1. с. 56-62.
25. Яковенко А.А. Особенности развития недостаточности питания у больных, получающих лечение хроническим гемодиализом: Автореф. дис. канд. мед. наук: 14.00.05. / СПбГУ.- Санкт-Петербург, 2008.- 15 с.
26. Aguilera A., Codoceo R., Bajo M.A. et al. Helicobacter pylori infection: a new cause of anorexia in peritoneal dialysis patients.// Perit Dial Int.- 2001; 21 Suppl 3:р. 152-6.
27. Alem A.M., Sherrard D.J., Weiss N.S. et al. Increased risk of hip fracture among patients with end-stage renal disease // Kidney Int.-2000.-Vol. 58, № 1.-P. 396
9.
28. Alvestrand A., Guttierez A. Relationship between nitrogen balance, protein, and energy intake in hemodialysis patients // Nephrol. Dial. Transplant.-1996.-Vol. 11, Suppl. 2.-P. 130-133.
29. Armstrong D., Veldhuyzen S.J., Chung S.A. et al. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test. // J Gastroenterol. 2005 Jun;19(6): Р.350-358.
30. Avram M.M., Goldwasser P., Erroa M. et al. Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic markers // Am. J. Kidney Dis.-1994.-Vol. 23, № 1.-P. 91-98.
31. Barazzoni R., Zhu X., Deboer M., Datta R. et al. Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and
AKT phosphorylation in rats with chronic kidney disease // Clinica Medica- Department of Clinical, Morphological and Technological Sciences, University of Trieste, Trieste, Italy, Kidney Int. 2010 Jan;77(1): Р.269-285.
32. Bastani B., Meneely M., Schmitz P.G. Serum bicarbonate is an independent determinant of protein catabolic rate in chronic hemodialysis // Am. J. Nephrol.- 1996.-Vol. 16, № 5.-P. 382-385.
33. Bayes B., Pastor M.C., Bonal J. et al. Homocysteine, C-reactive protein, lipid peroxidation and mortality in hemodialysis patients // Nephrol. Dial. Transplant. - 2003.-Vol. 18, № 1.-P. 106-112.
34. Bergstrom J. Nutrition and mortality in hemodialysis (Review) // J. Am. Soc. Nephrol.-1995.-Vol. 6, № 5.-P. 1329-1341.
35. Bergstrom J., Alvestrand A., Furst O. Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition // Kidney Int. - 1990.-Vol. 38.-P. 108-114.
36. Bergstrom J., Lindholm B., Lacson E. et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? // Seminars Dial.-2000.-Vol. 13.-P. 163-175.
37. Beto J.A. Which diet for which renal failure: making sense of the options // J. Am. Diet. Assoc.-1995.-Vol. 95, № 8.-P. 898-903.
38. Beto J., Bansal V.K., Hart S. et al. Hemodialysis prognostic nutrition index as a predictor for morbidity and mortality in hemodialysis patients and its correlation to adequacy of dialysis // J. Renal Nutr.-1999.-Vol. 9, № 1.-P. 2-8.
39. Blumenkrantz M.J., Kopple J.D., Gutman R.A. et al. Methods for assessing nutritional status of patients with renal failure // Am. J. Clin. Nutr.-1980.-Vol. 33, № 7.-P. 1567-1585.
40. Broglio F., Gottero C., Arvat E., Ghigo E. Hormone Research, Endocrine and Non-Endocrine Actions of Ghrelin // Hormone Research 2003; 59 (3): Р.109- 117.
41. Brunger M., Hulter H.N., Krapf R. Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: new cause of growth hormone insensitivity in humans // Kidney Int.-1997.-Vol. 51.-P. 205-215.
42. Buscher A.K., Buscher R., Hauffa B.P., Hoyer P.F. Alterations in appetiteregulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease// Pediatr Nephrol. 2010 Nov;25(11): Р. 295-301.
43. Beddhu S., Pappas L.M., Ramkumar N. et al. Effect of body size and body composition on survival in hemodialysis patients // J. Am. Soc. Nephrol.-2003.- Vol. 14, № 9.-P. 2366-2372.
44. Canan O., Ozcay F., Ozbay-Hosnut F. et al. Helicobacter pylori infection and gastroduodenal lesions in children with chronic kidney disease stage V// Pediatr Nephrol. 2012 Dec;27(12): Р.2269-74.
45. Cano A.E., Neil A.K., Kang J.Y. et al. Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis // Am J Gastroenterol 2007; 102 (9): Р. 1990-1997.
46. Cano N., Feinandes J.P., Lacombe P. et al. Statistical selection of nutritional parameters in hemodialyis patients // Kidney Int.-1987.-Vol. 32, Suppl. 22.-P. 5178-5180.
47. Carvalho K.T., Silva M.I.B., Bregman R. Nutritional profile of patients with chronic renal failure // J. of Renal Nutr.-2004.-Vol. 14, № 2.-P. 97-100.
48. Chan W., Valerie K.C., Chan J.C.M. Expression of insulin-like growth factor-1 in uremic rats: Growth hormone resistance and nutritional intake // Kidney Int. - 1993.-Vol. 43, № 4.-P. 790-795.
49. Chattopadhyay G., Basu K., Mukherjee S., Hazra B.R. Gastroduodenal mucosa in peptic ulcer: endoscopic and histological assessment// Trop Gastroenterol. 1997 Oct-Dec;18(4): Р.156-9.
50. Chen Y.-C., Chen H.-H., Yen J.-C., Chen S.-Y. Body composition in hemodialysis patients - is it different from that of normal subjects? // Clin. Nephrol.-2000.-Vol. 53, № 4.-P. 291-295.
51. Chertow G.M., Bullard A., Lazarus J.M. Nutrition and the dialysis prescription // Am. J. Nephrol.-1996.-Vol. 16, № 1.-P. 79-89.
52. Chertow G.M., Lowrie E.G., Wilmor D.W. et al. Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients // J. Am. Soc. Nephrol.-1995.-Vol. 6, № 1.-P. 75-81.
53. Chertow G.M., Lazarus J.M., Lew N.L. et al. Development of a population- specific regression equation to estimate total body water in hemodialysis patients // Kidney Int.-1997.-Vol. 51.-P. 1578-1582.
54. Chertow G.M., Jacobs D.O., Lazarus J.M. et al. Phase angle predicts survival in hemodialysis patients // J. Ren. Nutr.-1997.-Vol. 7.-P. 204-207.
55. Chertow G.M., Ackert K., Lew N.L. et al. Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients // Kidney Int.-2000.-Vol. 58, № 6.-P. 2512-2517.
56. Chou C.C., Bai C.H., Tsai S.C., Wu M.S. Low serum acylated ghrelin levels are associated with the development of cardiovascular disease in hemodialysis patients// Intern Med. 2010;49(19): Р.2057-64.
57. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation, 2000.
58. Cohn S.H., Brenna B.L., Yasumura S. et al. Evaluation of body composition and nitrogen content of renal patients on chronic dialysis as determined by total body neutron activation // Am. J. Nephrol.-1983.-Vol. 38, № 1.-P. 52-58.
59. Collins A.J., Ma J.Z., Umen A., Keshaviah P. Urea index and other predictors of hemodialysis patients survival // Am. J. Kidney Dis.-1993.-Vol. 23, № 2.-P. 272-282.
60. Cooper B.A., Bartlett L.H., Aslani A. et al. Validity of subjective global assessment as a nutritional market in end-stage renal disease // Am. J. Kidney Dis.-2002.-Vol. 40.-P. 126-132.
61. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention// Cancer Res. 1992 Dec 15;52(24):6735-40.
62. Coskun C., Kural A., Doventas Y., Koldas M., Ozturk H., Inal B.B., Gumus A. Hemodialysis and protein oxidation products.// Ann N Y Acad Sci. 2007 Apr;1100:404-8.
63. Daugirdas J.T. Simplified equations for monitoring Kt/v, PСRn, eKt/v, and ePCRn // Adv. Ren Replace Ther.-1995.-Vol. 2.-P. 295 - 304.
64. Date Y., Kojima M., Hosoda H. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.// Endocrinology. 2000 Nov;141(11):
Р.4255-61.
65. Deboer M.D., Zhu X., Levasseur P.R., Inui A. et al. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile // Endocrinology 2008; 149 (2): Р.827-835.
66. Delege M.H., Kirby D.F. Nutrition and renal disease // Practical Handbook of Nutrition in Clinical Practice / Kirby D.F., Dudrick S.J. - CRC Press: Boca Ratin- Ann Arbor-London-Tokyo, 1994.-P. 197-214.
67. DeFronzo R.A., Alvestrand A., Smith D. et al. Insulin resistance in uremia // J. Clin. Invest.-1981.-Vol.67, № 2.-P. 563-568.
69. Dixon M.F. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut. 2001 Jul;49(1):P.2-4.
70. Don B.R., Rosales L.M., Levine N.W. et al. Leptin is a negative acute phase protein in chronic hemodialysis patients // Kidney Int.-2001.-Vol. 59.-P. 11141120.
71. Druml W. Malnutrition is bad, but how can one detect malnutrition? // Nephrol. Dial. Transplant.-1997.-Vol. 12, № 11.-P. 2225-2227.
72. Elsayed N.M., Hamed S.T., El-Khatib M.M., El-Shehaby A.M. The relation between dual energy x-ray absorptiometry measurement of body fat composition and plasma ghrelin in patients with end-stage renal disease// Saudi Med J. 2009 Jan;30(1): Р.109-15.
73. European best practice guidelines on haemodialysis // Nephrol. Dial. Transplant.-2007.-Vol. 22, suppl.2.-P. 45-87.
74. Fain J.N., Madan A.K., Hiler M.L. et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans // Endocrinology. -
2004. -Vol. 145.-P. 2273-2282.
75. FAO/WHO. Energy and protein requirement // Report of a Joint FAO/WHO ad hoc Expert Committee. WHO. Techn. Rep. Ser. №2 522. Geneva, 1973.-P. 61-64.
76. Fatima A., Andrabi S., Wolf G., Engelmann M., Spina M.G. Urocortin 1 administered into the hypothalamic supraoptic nucleus inhibits food intake in freely fed and food-deprived rats // Amino Acids. 2013 Mar;44(3): Р.879-85.
77. Foley R.N., Parfrey P.S., Hamett J.D. et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease // Am. J. Kidney Dis.-1996.-Vol. 28.-P. 53-61.
78. Fouque D., Vennegoor M., ter Wee P. et al. EBPG guideline on nutrition.// Nephrol Dial Transplant. 2007 May;22 Suppl 2:ii45-87.
79. Fruhbeck G., Jebb S.A., Prentice A.M. Leptin: physiology and pathophysiology (Review) // Clinical physiology (Oxford).-1998.-Vol.18, № 5.-P. 399-419.
80. Garber A.J. Effects of paraphyroid hormone on skeletal muscle protein and amino acid metabolism in the rat // J. Clin. Invest.-1983.-Vol. 71, №2 6.-P. 18061821.
81. Garidotto G. Muscle amino acid metabolism and the control of muscle protein turnover in patients with chronic renal failure // Nutrition.-1999.-Vol. 15, № 2.- P. 145-155.
82. Gilmour E.R., Hartley G.H., Goodship T.H.J. Trace elements vitamins in renal disease // Nutrition and the Kidney / Mitch W.E., Klahr S.-Boston : Little, Brown and Co., 1993.-P. 114-131.
83. Giemsa G. Eine Vereinfachung und Vervollkommnung meiner Methylenazur- Methylenblau-Eosin-Farbemethode zur Erzielung der Romanowsky-Nochtschen Chromatinfarbung. 1904, Centralbl f Bakt etc 37: P.308-311.
84. Gokal R. Quality of life in patients on replacement therapy of chronic renal failure // Kidney Int.-1993.-Vol. 43, Suppl.40.-P. 23-27.
85. Goldwasser P., Michel M.A., Collier S. et al. Prealbumin and lipoprotein (a) in hemodialysis: Relationships with patients and vascular access survival // Am. J. Kidney Dis.-1993.-Vol. 22, № 1.-P. 215-225.
86. Graf L., Candelaria S., Doyle M,. Kaskel F. Nutrition assessment and hormonal influences on body composition in children with chronic kidney disease// Adv Chronic Kidney Dis. 2007 Apr;14(2): Р.215-23.
87. Grzegorzewska A. Protein catabolic rate (PCR), dietary protein intake (DPI) and metabolic acidosis// Nephrol Dial Transplant. 1999 Sep;14(9):P.2266-7.
88. Guarnieri G., Toigo G., Fiotti N. et al. Mechanisms of malnutrition in uremia // Kidney Int.-1997.-Vol. 52, Suppl. 62.-P. S-41-S-44.
89. Guebre-Egziabher F, Bernhard J, Geelen G. Leptin, Adiponectin, and Ghrelin Dysregulation in Chronic Kidney Disease // J Renal Nutrition 2005; 15 (1): Р.116-120.
90. Hakim R.M., Levin M. Malnutrition in hemodialysis patients // Am. J. Kidney Dis.-1993.-Vol. 21.-P. 125-137.
91. Heaf J. Adynamic bone disease and malnutrition-inflammation-cachexia syndrome.// Kidney Int. 2007 Jun;71(12): Р.1326.
92. Hirako M., Kamiya T., Misu N. et al. Impaired gastric motility and its relationship to gastrointestinal symptoms in patients with chronic renal failure// J Gastroenterol. 2005 Dec;40(12): Р.1116-22.
93. Holland D.C., Meers C., Lawlor M.E., Lam M. Serial prealbumin levels as predictors of outcomes in a retrospective cohort of peritoneal and hemodialysis patients // J. Ren. Nutr.-2001.-Vol. 11.-P. 129-138.
94. Jacob V., Le Carpentier J.E., Salzano S. et al. IGF-1 a marker of undernutrition in hemodialysis patients // Am. J. Clin. Nutr.-1990.-Vol. 52, № 1.-P. 39-44
95. Jarkovska Z., Rosicka M., Krsek M., Sulkova S. et al. Plasma ghrelin levels in patiens with End-Stage Renal Disease // Phisiological Research 2005 54: Р.403- 408.
96. Jobst E., Enriori P., Cowley M. The electrophysiology of feeding circuits. Trends // Endocrinology Metab 2004; 15: Р.488-499.
97. Johansen K.L., Mulligan K., Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving hemodialysis // J. Am. Med. Assoc.-1999.-Vol. 281, № 14.-P. 1275-1281.
98. Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention of Chronic Diseases. Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation // Geneva, Switzerland: World Health Organization.-2003.
100.Ikizler T.A., Hakim R.M. Nutrition in end-stage renal disease // Kidney Int.- 1996.-Vol. 50, № 2.-P. 343-357.
101.Ingenbleek Y., Bernstein L. The stressful condition as a nutritionally dependent adaptive dichomony // Nutrition.-1999.-Vol. 25, № 4.-P. 305-320.
102.Iseki K., Kawazoe N., Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients // Kidney Int.-1993.-Vol. 44, №2 1.-P. 115-119.
103.Ishimura E., Okuno S., Kim M. et al. Increasing body fat mass in the first year hemodialysis // J. Am. Soc. Nephrol.-2001.-Vol. 12, № 9.-P. 1921-1926.
104.Iwabuchi H., Matsuzaki K. The treatment of peptic ulcer in elderly CRF patients// Nihon Rinsho. 2002 Aug;60(8):P. 1601-5.
105.Kalender B., Ozdemir A.C., Yalug I., Dervisoglu E. Antidepressant treatment increases quality of life in patients with chronic renal failure.// Ren Fail. 2007; 29(7): Р.817-22.
106.Kasacka I. Review article - involvement of gastric APUD cells in chronic renal failure // Acta Histochem 2003; 105 (4): Р.319-327.
107.Kawashima J., Ohno S., Sakurada T., Takabayashi H., Kudo M., Ro S., Kato
S. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis // J Gastroenterol. 2009;44(10): Р.1046-54.
108.Kaysen GA, Kumar V. Inflammation in ESRD: causes and potential consequences// J Ren Nutr. 2003 Apr;13(2): Р.158-60.
109.Kaysen G.A. Malnutrition and the acute-phase reaction in dialysis patients: How to measure and how to distinguish // Nephrol. Dial. Transplant.-2000.-Vol. 15.-P. 1521-1524.
110. Kaysen G.A. Biological basis of hypoalbuminemia in ESRD // J. Am. Soc. Nephrol.-1998.-Vol. 9, № 12.-P. 2368-2376.
111. Kaysen G.A. The microinflammatory state in uremia: causes and potential consequences // J. Am. Soc. Nephrol.-2001.-Vol. 12.-P. 1549-1557.
112. Kaysen G.A., Rathore V., Shearer G.C., Depher Th.A. Mechanisms of hypoalbuminemia in hemodialysis patients // Kidney Int.-1995.-Vol. 48, № 2.- P. 510-516.
113. Kaysen G.A., Levin N.W. Why measure serum albumin levels? // J. Ren. Nutr.-2002.-Vol. 12.-P. 148-150.
114. Kayali A.G., Young V.R., Goodman M.N. Sensivity of myofibrillar proteins to glucocorticoid induced muscle proteolysis // Am. J. Physiol.-1987.-Vol. 252.- P. E621-E626.
115. Kimmel P.L., Phillips T.M., Simmens S.J. et al. Immunologic function and survival in hemodialysis patients // Kidney Int.-1998.-Vol. 54, №2 1.-P. 236-244.
116. Kloppenburg W.D., Stegeman C.A., de Jong P.E., Huisman R.M. Relating protein intake to nutritional status in haemodialysis patients: how to normalize the protein equivalent of total nitrogen appearance (PNA)?// Nephrol Dial Transplant. 1999 Sep;14(9): Р.2165-72.
117. Kopple J.D. National Kidney Foundation K/DOQI clinical practice.
guidelines for nutrition in chronic renal failure // Am. J. Kidney Dis.-2001.- Vol. 37.-P. S66-S70.
118. Kopple J.D. Effect of nutrition on morbidity and mortality in maintenance dialysis patients // Am. J. Kidney Dis.-1994.-Vol. 24, № 6.-P. 1002-1009.
119. Korbonits M., Goldstone A., Gueorguiev M., Grossman A. Ghrelin - a gormone with multiple functions // Front Neuroend crinol 2004; 25: Р.27-68.
120. Kojima M., Kangawa K. Drug Insight the function of ghrelin and its potential as a multitherapeutic hormone // Nature clinical practice Endocrinology and Metabolism 2006; 2 (2): Р.234-237.
121. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K.
Ghrelin is a growth-hormone-releasing acylated peptide from stomach. // Nature. 1999 Dec 9; 402(6762): Р.656-60.
122. Krieg J.Jr., Santos F., Chan J.C.M. Growth hormone, insulin-like growth factor and the kidney // Kidney Int.-1995.-Vol. 48, № 2.-P. 321-336.
123. Kutner N.G., Zhang R. Body mass index as a predictor of continued survival in older chronic dialysis patients // Int. Urol. Nephrol.-2001.-Vol. 32, № 3.-P. 441-448.
124. Hakim R.M., Levin M. Malnutrition in hemodialysis patients // Am. J. Kidney Dis.-1993.-Vol. 21, № 2.-P. 125-137.
125. Larsson J., Akerlind I., Permerth J., Hornqvist J.-O. The relation between nutritional state and quality of life in surgical patients // Eur. J. Surg.-1994.-Vol. 160, № 6-7.-P. 329-334.
126. Law M.R., Morris J.K., Wald N.J. et al. Serum albumin and mortality in the BUPA study //British United Provident. Assoc. Int. J. Epidemiol.-1994.-Vol. 23, № 1.-P. 38-41.
127. Lesourd B.M., Mazari L. Immune responses during recovery from protein- energy malnutrition // Clin. Nutr.-1997.-Vol. 16, Suppl. 1.-P. 37-46.
128. Louard R.J., Fryburg D.A., Gelfand R.A., Barrett E.J. Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle // J. Clin. Invest.-1992.-Vol. 90.-P. 2348-2354.
129. Louden J.D., Roberts R.R., Goodship T.H.S. Acidosis and nutrition // Kidney Int.-1999.-Vol. 56, Suppl. 73.-P. S-85-S-88.
130. Lowrie EG. Chronic dialysis treatment: clinical outcome and related processes of care// Am J Kidney Dis. 1994 Aug;24(2):255-66.
131. Lowrie E.G., Lew N.L. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities // Am. J. Kidney Dis.-1990.-Vol. 15, №2 5.-P. 458
482.
132. Lowrie E.G., Huang W.H., Lew N.L., Liu Y. The relative contribution of measured variables to death risk among hemodialysis patients // In: Friedman EA (ed). Death on Hemodialysis. Amsterdam: Kluwer Academic.-1994.-P. 121141.
133. Mak R.H., Bettinelli A., Turner C. et al. The influence of hyperparathyroidism on glucose metabolism in uremia // J. Clin. Endocrinol. Metab.-1985.-Vol. 60.- P. 229 - 233.
134. Mak R.H, Cheung W.W. Is ghrelin a biomarker for mortality in end-stage renal disease?// , Kidney Int. 2011 Apr;79(7): Р.697-9.
135. Malatino L.S., Mallamaci F., Benedetto F.A. et al. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end- stage renal disease// Am J Kidney Dis. 2000 Nov;36(5): Р.945-52.
136. Marcen R., Teruel J.L., de la Cal M.A., Gamez C. The impact of malnutrition in morbidity and mortality in stable haemodialysis patients. Spanish Cooperative Study of Nutrition in Hemodialysis// Nephrol Dial Transplant. 1997 Nov;12(11): Р.2324-31.
137. Matsuda K., Nishi Y., Okamatsu Y., Kojima M. et al. Ghrelin and leptin: a link between obesity and allergy // Journal of allergy and clinical Immunology (St Louis MO) 2006; 117 (3): Р.705-706.
138. Mafra D. Are Ghrelin and Leptin Involved in Food Intake and Body Mass Index in Maintenance Hemodialysis // J Renal Nutritoin 2010 May;20(3):P.151- 7.
139. Meier U., Gressner A. Endocrine regulation of Energy Metabolism: Review of Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin, Adiponectin and Resistin. Clinical Chemistry 2004; 50 (9):Р. 1511-1525.
140. Mendez-Sanchez N. Effect of Helicobacter pylori infection in gastric ghrelin expression and body weight // Gastroenterol 2007; 72 (4): Р. 359-364.
141. Misra V., Misra S.P., Shukla S.K. Endoscopic and histological changes in upper gastrointestinal tract of patients with chronic renal failure // Indian J. Pathol Microbiol 2004; 47 (2): Р.170-173.
142. Mitch W.E. Metabolic acidosis stimulates protein metabolism in uremia // Miner. Electrolyte Metab.-1996.-Vol. 2.-P. 62-65.
143. Mitch W.E., Price S.R., May R.S. et al. Metabolic consequences of uremia: extending the concept of adaptive responses to protein metabolism // Am. J. Kidney Dis.-1994.-Vol. 23, № 2.-P. 224-228.
144. Movilli E., Zani R., Carli O., Sangalli L. et al. Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study// Nephrol Dial Transplant. 1998 Jul;13(7): Р.1719-22.
145. Movilli E., Filippini M., Brunori G. et al. Influence of protein catabolic rate on nutritional status, morbidity and mortality in elderly uraemic patients on chronic haemodialysis: a prospective 3-year follow-up study// Nephrol Dial Transplant. 1995;10(4): Р.514-8.
146. Nair K.S., Ford G.C., Ekberg K. et al. Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients // J. Clin. Invest.-1995.-Vol. 95.-P. 2926-2937.
147.Nardone G., Rocco A., Fiorillo M. Helicobarter pylory infection in dyspeptic patients with and without chronic renal failure // Helicobacter 2005; 10 (1): Р. 53-58.
148.Naufel M.F., Bordon M., de Aquino T.M., Ribeiro E.B., de Abreu Carvalhaes Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease. JT Pediatr Nephrol. 2010 Dec;25(12): Р.2477-82.
149.Niebauer J., Clark A.L., Anker S.D., Coats A.J. Three year mortality in heart failure patients with very low left ventricular ejection fractions.// Int J Cardiol. 1999 Aug 31;70(3): Р.24.
150.Nieves M., Sulbaran J., Gaona C. et al. Gastroduodenitis and Helicobacter pylori in uremic patients// G E N. 1992 Apr-Jun;46(2): Р. 113-20.
151.Noori N., Kovesdy C.P., Dukkipati R. et al. Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation// Am J Nephrol. 2011;33(2): Р.157-67.
152.Nordfors L., Lonnqvist F., Heimburger O. et al. Low leptin gene expression and hyperleptinemia in chronic renal failure // Kidney Int.-1998.-Vol. 54.-P. 1267-1275.
153.O’Keefe S.J., Dicker J. Is plasma albumin concentration useful in the assessment of nutritional status of hospital patients? // Eng. J. Clin. Nutr.- 1988.- Vol. 42, № 1.-P. 41-45.
154.Oksa H., Ahonen K., Pasternack A., Marnela K.-M. Malnutrition in hemodialysis patients // Scand. J. Urol. Nephrol.-1991.-Vol. 25, № 2.-P. 157161.
155.Oldrizzi L., Rugiu C., De Biase V. et al. Factors influencing dietary compliance in patients with chronic renal failure on unsupplemented low-protein diet // Cotrib. Nephrol.-1990.-Vol. 81.-P. 9-15.
156. Oner-Iyidogan Y., Gurdol F., Kocak H., Oner P., Cetinalp-Demircan P., Caliskan Y., Kocak T., Turkmen A. Appetite-regulating hormones in chronic kidney disease patients// J Ren Nutr. 2011 Jul;21(4): Р.316-21.
157. Osawa H. Ghrelin and Helicobacter pylori infection // World J Gastroenterol 2008; 14 (41): Р. 6327-6333.
158. Owen W.F., Lew N.L., Liu Y. et al. The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis // N. Eng. J. Med.-1993.-Vol. 329, № 14.-P. 1001-1006.
159. Owen W.F., Lowrie E.G. C-reactive protein as an outcome predictor for maintenance hemodialysis patients // Kidney Int.-1998.-Vol. 54.-P. 627-636.
160. Panzetta G. Protein intake does not depend on the dose of dialysis delivered- -provided Kt/V is adequate.// Nephrol Dial Transplant. 1995 Dec;10(12): Р.2286- 9.
161. Parker T.F., Laird N.M., Lowrie E.G. Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality, and patient withdrawal // Kidney Int.-1983.-Vol. 23, Suppl. 13.-P. 42-49.
162. Pollock C.A., Allen B.J., Warden R.A. et al. Total - body nitrogen by neutron activation in maintenance dialysis // Am. J. Nephrol.-1990.-Vol. 19, №2 1.-P. 3845.
163. Pollock C.A., Ibels L.S., Ayass W. et al. Total body nitrogen as a prognostic marker maintemence dialysis // J. Am. Soc. Nephrol.-1995.-Vol. 16.-P. 82-88.
164. Popovic V. Ghrelin // Current Opinion in Endocrinology @ diabetes 2006; 13: Р.70- 75.
165. Pressman M.R., Benz R.L. Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure // Kidney Int.-1993.-Vol. 43, № 5.-P. 1134-1139.
166. Pupim L. B., Ikizler T. A. Uremic Malnutrition: New Insights Into an Old Problem: Review // Seminars in Dialysis (Cambridge, Ma).-2003.-Vol.16, № 3.-P. 224-232.
167. Rahmati M.A., Craig R.G., Homel P., Kaysen G.A., Levin N.W. Serum markers of periodontal disease status and inflammation in hemodialysis patients// Am J Kidney Dis. 2002 Nov;40(5): Р.983-9.
168. Rasmi Y., Farshid S., Makhdomi K. Effect of duration on hemodialysis on prevalence of Helicobacter pylori infection// Saudi J Kidney Dis Transpl. 2012 May;23(3): Р. 489-92.
169. Reaich D., Channon S.M., Scrimgeour C.M. et al. Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation // Am.
J. Physiol.-1993.-Vol. 265.-P. 230-235.
170. Rocco A., Fiorillo M. Helicobarter pylory infection in dyspeptic patients with and without chronic renal failure // Helicobacter 2005; 10 (1): Р. 53-58.
171. Ross R., Despres J.P. Abdominal obesity, insulin resistance, and the metabolic syndrome: contribution of physical activity/exercise// Obesity (Silver Spring). 2009 Dec;17 Suppl 3: P.S1-2.
172. Rosman J.B., Brandl M., Langer K. Amino acid profiles during prolonged dietary protein restriction // Contrib. Nephrol.-1990.-Vol. 81.-P. 188-193
173. Sanaka T., Shinole M., Audo M. et al. IGF-1 as an early indicator malnutrition in patients with end-stage renal disease // Nephron.-1994.-Vol. 67, № 1.-P. 7381.
174. Sardesai V.M. Fundamentals of nutrition // In: Dekker M (ed) / Introduction to Clinical Nutrition. New York: Sardesai.-1998.-P. 1-13.
175. Sargent J.A., Gotch F.A. Mathematic modeling of dialysis therapy // Kidney Int.-1980.-Vol. 18, № 10.-P. 2-10.
176. Schaefer F., Chen Y., Tsao T. et al. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia // J. Clin. Invest.- 2001.-Vol. 108.-P. 467-475.
177. Schmidt A., Fabrizii V., Maier C. et al . Normal regulation of elevated plasma ghrelin concentrations in dialysis patients // Wien Klin Wochenschr. 2004 Apr 30;116(7-8): Р.235-9.
178. Schofield C., Ashworth A. Why have mortality rates for severe malnutrition remained so high ? // Bull. World Health Organ.-1996.-Vol. 74, № 2.-P. 223229.
179. Scholze A., Tepel M. Role of leptin in reverse epidemiology in chronic kidney disease// Semin Dial. 2007 Nov-Dec;20(6): Р.534-8.
180. Simonian H.P., Kresge K.M., Boden G.H., Parkman H.P. Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferents stimulation mediating ghrelin release // Neorogastroenterol Motil 2005; 17: Р. 348-354.
181. Suneja M., Murry D.J., Stokes J.B., Lim V.S. Hormonal regulation of energy- protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes// Am J Physiol Endocrinol Metab. 2011 Jan;300(1): Р. E55-64.
182. Stenvinkel P., Heimburger O., Paultre F. et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure // Kidney Int.-1999.-Vol. 55.-P. 1899-1911.
183. Stenvinkel P., Heimburger O., Lindholm B. et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation, and atherosclerosis (MIA syndrome) // Nephrol. Dial. Transplant.-2000.-Vol. 15, № 7.-P. 953-960.
184. Suhardjono, Malnutrition-inflammation syndrome in a hemodialysis population: the influence of polymorphic IL-6-174 and IL-10-1082 genes// Acta Med Indones. 2006 Jul-Sep;38(3): Р.145-9.
185. Taylor M.S., Hwang Y., Hsiao P.Y. Ghrelin O-acyltransferase assays and inhibition// Methods Enzymol. 2012;514: Р.205-28.
186. The European Helicobacter pylori Study Group (1997) Current European concepts in the management of Helicobacter pylori infection: The Maastricht Consensus Report. Gut, 41: Р.8-13.
187. Tong J., Prigeon R.L., Davis H.W. et. al. Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans // J Clin Endocrinol Metab. 2013 Jun;98(6): Р. 2536-43.
188. Torun B., Chew F. Protein - energy malnutrition // Modern nutrition in Health and Disease. (8th ed.) / Shils M. E., Olson J. A., Shike M. - Williams and Wilkins.-1994.-P. 950-976.
189. Uribarri J., Protein catabolic rate may underestimate dietary protein intake in hemodialysis patients// Nephron. 1999 Jun;82(2): Р.97-9.
190. Yang Y.J., Sheu B.S., Yang H.B., Lu C.C., Chuang C.C. Eradication of Helicobacter pylori increases childhood growth and serum acylated ghrelin levels // World J Gastroenterol. 2012 Jun 7;18(21):Р.2674-81.
191. Yao Q., Lindholm B., Stenvinkel P. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients // Hemodialysis Int.-2004.-Vol. 8, № 2.-P. 118-129.
192. Young G.A., Swanepoel C.R., Croft M.R. et al. Anthropometry and plasma valine, amimo acids, and proteins in the nutritional assessment of hemodialysis patients // Kidney Int.-1982.-Vol. 21, № 3.-P. 492-499.
193. Yoshimoto A., Mori K., Sugawara A. Plasma ghrelin and desacyl ghrelin concentrations in renal failure//J Am Soc Nephrol. 2002 Nov;13(11):P.2748-52.
194. van der Lely A.J., Tschop M., Heiman M., Ghigo E. Biologycal, physiological, pathophysiological and pharmacological aspects of ghrelin // Endocr Rev 2004; 25:Р. 426-457.
195. Var C., Gultekin F., Candan F. et al. The effects of hemodialysis on duodenal and gastric mucosal changes in uremic patients// Clin Nephrol. 1996 May;45(5):P.310-4.
196. Verdery R.B., Goldberg A.P. Hypocholesterolemia as a predictor of death: A prospective study of 224 nursing home residents // J. Gerontol.-1991.-Vol. 46, № 3.-P. М84-М90.
197. Walser M. Dialysis and protein malnutrition // Kidney Int.-1999.-Vol.56, № 1.-P. 353.
198. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome // Endocr. Rev.-2000.-Vol. 21.-P. 697-738.
199. Wang L., Stengel A., Goebel-Stengel M., Shaikh A., Yuan P.Q., Tache Y.
Intravenous injection of urocortin 1 induces a CRF2 mediated increase in circulating ghrelin and glucose levels through distinct mechanisms in rats// Peptides. 2013 Jan;39: Р.164-70.
200. Wee A., Kang J.Y., Ho M.S. et al., Gastroduodenal mucosa in uraemia: endoscopic and histological correlation and prevalence of helicobacter-like organisms// Gut. 1990 Oct;31(10):Р.1093-6.
201. Wittert G., Chapman I. Physiology of gut hormones an overview // Current Opinion in Endocrinology and Diabetes (Hagerstown, Md) 2006; 13 (1): Р.36-
41.
202. Wolfson M., Strong C.J., Mintum D. et al. Nutritional status and limphocyte function in maintenance hemodialysis patients // Am. J. Clin Nutr.-1984.-Vol. 37, № 4.-P. 547 - 555.
203. Zizzari P., Halem H., Taylor J. et al. Endogenous ghrelin regulates episodic GH secretion by amplifying GH pulse amplitude evidence from antagonism of the GHS-R1a receptor // Endocrinology 2005; 146: Р.3836-3842.
1. Аруин Л.И. Значение биопсий при язвенной болезни// арх. Патологии, 1989 - Т.51, №7. - с. 70-76.
2. Аруин Л.И. Новая классификация гастрита// Рос. журн. гастроэнтерол., гепатол. и колопроктол. 1997. Т.ТШ. N3. с. 82-85.
3. Анашкин В. А., Перлин Д. В., Хасабов Н. Н., Яковенко А. В., Яковенко Э.П., Обуховский Б. И. Состояние верхних отделов пищеварительного тракта и распространенность Helicobacter pylori инфекции у больных после трансплантации почки// "Нефрология и диализ", Т. 5, 2003 г., №4.
4. Барановский А. Ю., Кондрашина Е.А., Назаренко Л.И. Диетология: Руководство. 4-е изд. /Под ред. А.Ю.Барановского - СПб.: Питер, 2012.- с.1024.
5. Голофеевский В.Ю. Введение в клиническую морфологию желудка и двенадцатиперстной кишки// СПБ. Фолиант, 2005 год - с.6-15.
6. Григорьева Н.Д. Диетическая коррекция метаболических нарушений у больных, получающих лечение хроническим гемодиализом: Автореф. дис. канд. мед. наук: 14.00.05. / СПбГМУ- Санкт-Петербург, 1999 - с.18.
7. Дружинин П.В., Новиков Л.Ф., Лысиков Ю.А. Основы нутрициологии. Концепция рационального и сбалансированного питания (часть 1) // НИИ Питания РАМН. - 2010 - с.120.
8. Луфт В. М., Хорошилов И. Е. Нутриционная поддержка больных в клинической практике// ВмедА, СПб. - 1997- с.120.
9. Мартиросов Э.Г. Методы определения и оценки физического развития // Спортивная медицина и лечебная физкультура / Под
ред. А.И. Журавлевой, Н.Д. Граевской. - М.: Медицина, 1993 - с.117-138.
10. Матюшечкин Е.В., Шишкин А.Н., Серебряная Н.Б., Кареев В.Е., Тимоховская Г.Ю. Цитокиновый статус и клинико-морфологические особенности гастродуоденальной зоны у больных, получающих заместительную почечную терапию // Нефрология 2007; 11 (4): с.64-69.
11. Милованов Ю.С. Нутритивный статус у больных ХБП на додиализном этапе// Вестник научно-технического развития, ФППО (В) ММА им. И.М. Сеченова - 2010.- №3(31), с.11-23.
12. Петрова Н.Н., Яковенко И.А. Качество жизни больных при лечении хронической почечной недостаточности методом гемодиализа // Сборник материалов рабочего совещания нефрологов Северо-Запада России. 16 мая 1996 г., Санкт-Петербург, Россия - СПб.- 1996.- с. 83 - 85.
13. Райхельсон К.Л. Влияние нутриционного статуса и гастродуоденальной патологии на прогноз и течение терминальной стадии хронической почечной недостаточности при применении активных методов лечения (гемодиализ, перитонеальный диализ, трансплантация почек): Автореф. дис. канд. мед. наук.- 14.00.05. / МАПО СПб.- Санкт-Петербург, 1999.- с.24.
14. Рудман Д. Оценка состояния питания // Внутренние болезни /Браунвальд
Е., Иссельбах К.Дж., Петерсдорф Р.Г.(Пер. с англ., в 10 кн.).- М.: Медицина- 1993.-Кн. 2.- с. 379.
15. Румянцев А.Ш., Коростелева Н.Ю. Влияние физических тренировок на белковый катаболизм при терапии гемодиализом // Нефрология- 1998.-Т. 2, № 2. - с. 80-83.
16. Рысс Е.С., Рябов С.И., Лутошкин М.Б., Панина И.Ю. Пищеварительная система // Лечение хронической почечной недостаточности / Под ред. С.И. Рябова. - СПб.: Фолиант- 1997. - с. 11-25.
17. Самсонов В.А. Язвенная болезнь. Новые материалы к патоморфологии основных ее форм. - Петрозаводск: Карелия -1975. - с.261.
18. Хорошилов И.Е., Панов П.Б., под ред. А.В. Шаброва. Клиническая нутрициология // Учеб.пособие, ЭЛБИ-СПб. - 2009- с.284.
19. Шакурова Н. Р. Особенности патоморфоза слизистой оболочки желудка и луковицы двенадцатиперстной кишки при Helicobacter pylori - ассоциированной язвенной болезни с различными вариантами клинического течения. Автореф. дис. канд. мед. наук.- 14.00.05 - внутренние болезни 03.00.25 - гистология, цитология, клеточная биология/ ГОУ ВПО Сибирский государственный медицинский университет Росздрава.- Томск- 2009. - с.3.
20. Шептулин А.А., Инфекция Helicobacter pylori и рак желудка: современное состояние проблемы. Российский журнал гастроэнтерологии, гепатологии, колопроктологии - 2012.- с. 77-82.
21. Шилова Е.М., Козловской Л.В. Коррекция нутритивных нарушений у больных хронической болезнью почек на додиализном этапе// Учебное пособие, Издательский дом «Русский врач», Москва. - 2009 -с. 4-13.
22. Шостка Г. Д., Долгодворов А. Ф., Команденко М. С. Показания к началу гемодиализной терапии у больных с хронической почечной недостаточностью // Нефрология.-1999.-Т. 3, № 1.-с. 14-19.
23. Яковенко А.А., Асанина Ю.Ю., Кучер А.Г., Бовкун И.В., Румянцев А.Ш., Вадюхина М.В. Особенности патогенеза недостаточности питания у больных с хронической почечной недостаточностью, получающих лечение хроническим гемодиализом// Нефрология - 2008. Т. 12. № 3. с. 56-65..
24. Яковенко А.А., Кучер А.Г., Румянцев А.Ш. Значение интерлейкина-6 в патогенезе «уремической недостаточности питания» у пациентов с терминальной почечной недостаточностью, получающих лечение хроническим гемодиализом //Нефрология - 2010. Т. 14. № 1. с. 56-62.
25. Яковенко А.А. Особенности развития недостаточности питания у больных, получающих лечение хроническим гемодиализом: Автореф. дис. канд. мед. наук: 14.00.05. / СПбГУ.- Санкт-Петербург, 2008.- 15 с.
26. Aguilera A., Codoceo R., Bajo M.A. et al. Helicobacter pylori infection: a new cause of anorexia in peritoneal dialysis patients.// Perit Dial Int.- 2001; 21 Suppl 3:р. 152-6.
27. Alem A.M., Sherrard D.J., Weiss N.S. et al. Increased risk of hip fracture among patients with end-stage renal disease // Kidney Int.-2000.-Vol. 58, № 1.-P. 396
9.
28. Alvestrand A., Guttierez A. Relationship between nitrogen balance, protein, and energy intake in hemodialysis patients // Nephrol. Dial. Transplant.-1996.-Vol. 11, Suppl. 2.-P. 130-133.
29. Armstrong D., Veldhuyzen S.J., Chung S.A. et al. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test. // J Gastroenterol. 2005 Jun;19(6): Р.350-358.
30. Avram M.M., Goldwasser P., Erroa M. et al. Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic markers // Am. J. Kidney Dis.-1994.-Vol. 23, № 1.-P. 91-98.
31. Barazzoni R., Zhu X., Deboer M., Datta R. et al. Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and
AKT phosphorylation in rats with chronic kidney disease // Clinica Medica- Department of Clinical, Morphological and Technological Sciences, University of Trieste, Trieste, Italy, Kidney Int. 2010 Jan;77(1): Р.269-285.
32. Bastani B., Meneely M., Schmitz P.G. Serum bicarbonate is an independent determinant of protein catabolic rate in chronic hemodialysis // Am. J. Nephrol.- 1996.-Vol. 16, № 5.-P. 382-385.
33. Bayes B., Pastor M.C., Bonal J. et al. Homocysteine, C-reactive protein, lipid peroxidation and mortality in hemodialysis patients // Nephrol. Dial. Transplant. - 2003.-Vol. 18, № 1.-P. 106-112.
34. Bergstrom J. Nutrition and mortality in hemodialysis (Review) // J. Am. Soc. Nephrol.-1995.-Vol. 6, № 5.-P. 1329-1341.
35. Bergstrom J., Alvestrand A., Furst O. Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition // Kidney Int. - 1990.-Vol. 38.-P. 108-114.
36. Bergstrom J., Lindholm B., Lacson E. et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? // Seminars Dial.-2000.-Vol. 13.-P. 163-175.
37. Beto J.A. Which diet for which renal failure: making sense of the options // J. Am. Diet. Assoc.-1995.-Vol. 95, № 8.-P. 898-903.
38. Beto J., Bansal V.K., Hart S. et al. Hemodialysis prognostic nutrition index as a predictor for morbidity and mortality in hemodialysis patients and its correlation to adequacy of dialysis // J. Renal Nutr.-1999.-Vol. 9, № 1.-P. 2-8.
39. Blumenkrantz M.J., Kopple J.D., Gutman R.A. et al. Methods for assessing nutritional status of patients with renal failure // Am. J. Clin. Nutr.-1980.-Vol. 33, № 7.-P. 1567-1585.
40. Broglio F., Gottero C., Arvat E., Ghigo E. Hormone Research, Endocrine and Non-Endocrine Actions of Ghrelin // Hormone Research 2003; 59 (3): Р.109- 117.
41. Brunger M., Hulter H.N., Krapf R. Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: new cause of growth hormone insensitivity in humans // Kidney Int.-1997.-Vol. 51.-P. 205-215.
42. Buscher A.K., Buscher R., Hauffa B.P., Hoyer P.F. Alterations in appetiteregulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease// Pediatr Nephrol. 2010 Nov;25(11): Р. 295-301.
43. Beddhu S., Pappas L.M., Ramkumar N. et al. Effect of body size and body composition on survival in hemodialysis patients // J. Am. Soc. Nephrol.-2003.- Vol. 14, № 9.-P. 2366-2372.
44. Canan O., Ozcay F., Ozbay-Hosnut F. et al. Helicobacter pylori infection and gastroduodenal lesions in children with chronic kidney disease stage V// Pediatr Nephrol. 2012 Dec;27(12): Р.2269-74.
45. Cano A.E., Neil A.K., Kang J.Y. et al. Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis // Am J Gastroenterol 2007; 102 (9): Р. 1990-1997.
46. Cano N., Feinandes J.P., Lacombe P. et al. Statistical selection of nutritional parameters in hemodialyis patients // Kidney Int.-1987.-Vol. 32, Suppl. 22.-P. 5178-5180.
47. Carvalho K.T., Silva M.I.B., Bregman R. Nutritional profile of patients with chronic renal failure // J. of Renal Nutr.-2004.-Vol. 14, № 2.-P. 97-100.
48. Chan W., Valerie K.C., Chan J.C.M. Expression of insulin-like growth factor-1 in uremic rats: Growth hormone resistance and nutritional intake // Kidney Int. - 1993.-Vol. 43, № 4.-P. 790-795.
49. Chattopadhyay G., Basu K., Mukherjee S., Hazra B.R. Gastroduodenal mucosa in peptic ulcer: endoscopic and histological assessment// Trop Gastroenterol. 1997 Oct-Dec;18(4): Р.156-9.
50. Chen Y.-C., Chen H.-H., Yen J.-C., Chen S.-Y. Body composition in hemodialysis patients - is it different from that of normal subjects? // Clin. Nephrol.-2000.-Vol. 53, № 4.-P. 291-295.
51. Chertow G.M., Bullard A., Lazarus J.M. Nutrition and the dialysis prescription // Am. J. Nephrol.-1996.-Vol. 16, № 1.-P. 79-89.
52. Chertow G.M., Lowrie E.G., Wilmor D.W. et al. Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients // J. Am. Soc. Nephrol.-1995.-Vol. 6, № 1.-P. 75-81.
53. Chertow G.M., Lazarus J.M., Lew N.L. et al. Development of a population- specific regression equation to estimate total body water in hemodialysis patients // Kidney Int.-1997.-Vol. 51.-P. 1578-1582.
54. Chertow G.M., Jacobs D.O., Lazarus J.M. et al. Phase angle predicts survival in hemodialysis patients // J. Ren. Nutr.-1997.-Vol. 7.-P. 204-207.
55. Chertow G.M., Ackert K., Lew N.L. et al. Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients // Kidney Int.-2000.-Vol. 58, № 6.-P. 2512-2517.
56. Chou C.C., Bai C.H., Tsai S.C., Wu M.S. Low serum acylated ghrelin levels are associated with the development of cardiovascular disease in hemodialysis patients// Intern Med. 2010;49(19): Р.2057-64.
57. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation, 2000.
58. Cohn S.H., Brenna B.L., Yasumura S. et al. Evaluation of body composition and nitrogen content of renal patients on chronic dialysis as determined by total body neutron activation // Am. J. Nephrol.-1983.-Vol. 38, № 1.-P. 52-58.
59. Collins A.J., Ma J.Z., Umen A., Keshaviah P. Urea index and other predictors of hemodialysis patients survival // Am. J. Kidney Dis.-1993.-Vol. 23, № 2.-P. 272-282.
60. Cooper B.A., Bartlett L.H., Aslani A. et al. Validity of subjective global assessment as a nutritional market in end-stage renal disease // Am. J. Kidney Dis.-2002.-Vol. 40.-P. 126-132.
61. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention// Cancer Res. 1992 Dec 15;52(24):6735-40.
62. Coskun C., Kural A., Doventas Y., Koldas M., Ozturk H., Inal B.B., Gumus A. Hemodialysis and protein oxidation products.// Ann N Y Acad Sci. 2007 Apr;1100:404-8.
63. Daugirdas J.T. Simplified equations for monitoring Kt/v, PСRn, eKt/v, and ePCRn // Adv. Ren Replace Ther.-1995.-Vol. 2.-P. 295 - 304.
64. Date Y., Kojima M., Hosoda H. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.// Endocrinology. 2000 Nov;141(11):
Р.4255-61.
65. Deboer M.D., Zhu X., Levasseur P.R., Inui A. et al. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile // Endocrinology 2008; 149 (2): Р.827-835.
66. Delege M.H., Kirby D.F. Nutrition and renal disease // Practical Handbook of Nutrition in Clinical Practice / Kirby D.F., Dudrick S.J. - CRC Press: Boca Ratin- Ann Arbor-London-Tokyo, 1994.-P. 197-214.
67. DeFronzo R.A., Alvestrand A., Smith D. et al. Insulin resistance in uremia // J. Clin. Invest.-1981.-Vol.67, № 2.-P. 563-568.
69. Dixon M.F. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut. 2001 Jul;49(1):P.2-4.
70. Don B.R., Rosales L.M., Levine N.W. et al. Leptin is a negative acute phase protein in chronic hemodialysis patients // Kidney Int.-2001.-Vol. 59.-P. 11141120.
71. Druml W. Malnutrition is bad, but how can one detect malnutrition? // Nephrol. Dial. Transplant.-1997.-Vol. 12, № 11.-P. 2225-2227.
72. Elsayed N.M., Hamed S.T., El-Khatib M.M., El-Shehaby A.M. The relation between dual energy x-ray absorptiometry measurement of body fat composition and plasma ghrelin in patients with end-stage renal disease// Saudi Med J. 2009 Jan;30(1): Р.109-15.
73. European best practice guidelines on haemodialysis // Nephrol. Dial. Transplant.-2007.-Vol. 22, suppl.2.-P. 45-87.
74. Fain J.N., Madan A.K., Hiler M.L. et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans // Endocrinology. -
2004. -Vol. 145.-P. 2273-2282.
75. FAO/WHO. Energy and protein requirement // Report of a Joint FAO/WHO ad hoc Expert Committee. WHO. Techn. Rep. Ser. №2 522. Geneva, 1973.-P. 61-64.
76. Fatima A., Andrabi S., Wolf G., Engelmann M., Spina M.G. Urocortin 1 administered into the hypothalamic supraoptic nucleus inhibits food intake in freely fed and food-deprived rats // Amino Acids. 2013 Mar;44(3): Р.879-85.
77. Foley R.N., Parfrey P.S., Hamett J.D. et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease // Am. J. Kidney Dis.-1996.-Vol. 28.-P. 53-61.
78. Fouque D., Vennegoor M., ter Wee P. et al. EBPG guideline on nutrition.// Nephrol Dial Transplant. 2007 May;22 Suppl 2:ii45-87.
79. Fruhbeck G., Jebb S.A., Prentice A.M. Leptin: physiology and pathophysiology (Review) // Clinical physiology (Oxford).-1998.-Vol.18, № 5.-P. 399-419.
80. Garber A.J. Effects of paraphyroid hormone on skeletal muscle protein and amino acid metabolism in the rat // J. Clin. Invest.-1983.-Vol. 71, №2 6.-P. 18061821.
81. Garidotto G. Muscle amino acid metabolism and the control of muscle protein turnover in patients with chronic renal failure // Nutrition.-1999.-Vol. 15, № 2.- P. 145-155.
82. Gilmour E.R., Hartley G.H., Goodship T.H.J. Trace elements vitamins in renal disease // Nutrition and the Kidney / Mitch W.E., Klahr S.-Boston : Little, Brown and Co., 1993.-P. 114-131.
83. Giemsa G. Eine Vereinfachung und Vervollkommnung meiner Methylenazur- Methylenblau-Eosin-Farbemethode zur Erzielung der Romanowsky-Nochtschen Chromatinfarbung. 1904, Centralbl f Bakt etc 37: P.308-311.
84. Gokal R. Quality of life in patients on replacement therapy of chronic renal failure // Kidney Int.-1993.-Vol. 43, Suppl.40.-P. 23-27.
85. Goldwasser P., Michel M.A., Collier S. et al. Prealbumin and lipoprotein (a) in hemodialysis: Relationships with patients and vascular access survival // Am. J. Kidney Dis.-1993.-Vol. 22, № 1.-P. 215-225.
86. Graf L., Candelaria S., Doyle M,. Kaskel F. Nutrition assessment and hormonal influences on body composition in children with chronic kidney disease// Adv Chronic Kidney Dis. 2007 Apr;14(2): Р.215-23.
87. Grzegorzewska A. Protein catabolic rate (PCR), dietary protein intake (DPI) and metabolic acidosis// Nephrol Dial Transplant. 1999 Sep;14(9):P.2266-7.
88. Guarnieri G., Toigo G., Fiotti N. et al. Mechanisms of malnutrition in uremia // Kidney Int.-1997.-Vol. 52, Suppl. 62.-P. S-41-S-44.
89. Guebre-Egziabher F, Bernhard J, Geelen G. Leptin, Adiponectin, and Ghrelin Dysregulation in Chronic Kidney Disease // J Renal Nutrition 2005; 15 (1): Р.116-120.
90. Hakim R.M., Levin M. Malnutrition in hemodialysis patients // Am. J. Kidney Dis.-1993.-Vol. 21.-P. 125-137.
91. Heaf J. Adynamic bone disease and malnutrition-inflammation-cachexia syndrome.// Kidney Int. 2007 Jun;71(12): Р.1326.
92. Hirako M., Kamiya T., Misu N. et al. Impaired gastric motility and its relationship to gastrointestinal symptoms in patients with chronic renal failure// J Gastroenterol. 2005 Dec;40(12): Р.1116-22.
93. Holland D.C., Meers C., Lawlor M.E., Lam M. Serial prealbumin levels as predictors of outcomes in a retrospective cohort of peritoneal and hemodialysis patients // J. Ren. Nutr.-2001.-Vol. 11.-P. 129-138.
94. Jacob V., Le Carpentier J.E., Salzano S. et al. IGF-1 a marker of undernutrition in hemodialysis patients // Am. J. Clin. Nutr.-1990.-Vol. 52, № 1.-P. 39-44
95. Jarkovska Z., Rosicka M., Krsek M., Sulkova S. et al. Plasma ghrelin levels in patiens with End-Stage Renal Disease // Phisiological Research 2005 54: Р.403- 408.
96. Jobst E., Enriori P., Cowley M. The electrophysiology of feeding circuits. Trends // Endocrinology Metab 2004; 15: Р.488-499.
97. Johansen K.L., Mulligan K., Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving hemodialysis // J. Am. Med. Assoc.-1999.-Vol. 281, № 14.-P. 1275-1281.
98. Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention of Chronic Diseases. Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation // Geneva, Switzerland: World Health Organization.-2003.
100.Ikizler T.A., Hakim R.M. Nutrition in end-stage renal disease // Kidney Int.- 1996.-Vol. 50, № 2.-P. 343-357.
101.Ingenbleek Y., Bernstein L. The stressful condition as a nutritionally dependent adaptive dichomony // Nutrition.-1999.-Vol. 25, № 4.-P. 305-320.
102.Iseki K., Kawazoe N., Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients // Kidney Int.-1993.-Vol. 44, №2 1.-P. 115-119.
103.Ishimura E., Okuno S., Kim M. et al. Increasing body fat mass in the first year hemodialysis // J. Am. Soc. Nephrol.-2001.-Vol. 12, № 9.-P. 1921-1926.
104.Iwabuchi H., Matsuzaki K. The treatment of peptic ulcer in elderly CRF patients// Nihon Rinsho. 2002 Aug;60(8):P. 1601-5.
105.Kalender B., Ozdemir A.C., Yalug I., Dervisoglu E. Antidepressant treatment increases quality of life in patients with chronic renal failure.// Ren Fail. 2007; 29(7): Р.817-22.
106.Kasacka I. Review article - involvement of gastric APUD cells in chronic renal failure // Acta Histochem 2003; 105 (4): Р.319-327.
107.Kawashima J., Ohno S., Sakurada T., Takabayashi H., Kudo M., Ro S., Kato
S. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis // J Gastroenterol. 2009;44(10): Р.1046-54.
108.Kaysen GA, Kumar V. Inflammation in ESRD: causes and potential consequences// J Ren Nutr. 2003 Apr;13(2): Р.158-60.
109.Kaysen G.A. Malnutrition and the acute-phase reaction in dialysis patients: How to measure and how to distinguish // Nephrol. Dial. Transplant.-2000.-Vol. 15.-P. 1521-1524.
110. Kaysen G.A. Biological basis of hypoalbuminemia in ESRD // J. Am. Soc. Nephrol.-1998.-Vol. 9, № 12.-P. 2368-2376.
111. Kaysen G.A. The microinflammatory state in uremia: causes and potential consequences // J. Am. Soc. Nephrol.-2001.-Vol. 12.-P. 1549-1557.
112. Kaysen G.A., Rathore V., Shearer G.C., Depher Th.A. Mechanisms of hypoalbuminemia in hemodialysis patients // Kidney Int.-1995.-Vol. 48, № 2.- P. 510-516.
113. Kaysen G.A., Levin N.W. Why measure serum albumin levels? // J. Ren. Nutr.-2002.-Vol. 12.-P. 148-150.
114. Kayali A.G., Young V.R., Goodman M.N. Sensivity of myofibrillar proteins to glucocorticoid induced muscle proteolysis // Am. J. Physiol.-1987.-Vol. 252.- P. E621-E626.
115. Kimmel P.L., Phillips T.M., Simmens S.J. et al. Immunologic function and survival in hemodialysis patients // Kidney Int.-1998.-Vol. 54, №2 1.-P. 236-244.
116. Kloppenburg W.D., Stegeman C.A., de Jong P.E., Huisman R.M. Relating protein intake to nutritional status in haemodialysis patients: how to normalize the protein equivalent of total nitrogen appearance (PNA)?// Nephrol Dial Transplant. 1999 Sep;14(9): Р.2165-72.
117. Kopple J.D. National Kidney Foundation K/DOQI clinical practice.
guidelines for nutrition in chronic renal failure // Am. J. Kidney Dis.-2001.- Vol. 37.-P. S66-S70.
118. Kopple J.D. Effect of nutrition on morbidity and mortality in maintenance dialysis patients // Am. J. Kidney Dis.-1994.-Vol. 24, № 6.-P. 1002-1009.
119. Korbonits M., Goldstone A., Gueorguiev M., Grossman A. Ghrelin - a gormone with multiple functions // Front Neuroend crinol 2004; 25: Р.27-68.
120. Kojima M., Kangawa K. Drug Insight the function of ghrelin and its potential as a multitherapeutic hormone // Nature clinical practice Endocrinology and Metabolism 2006; 2 (2): Р.234-237.
121. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K.
Ghrelin is a growth-hormone-releasing acylated peptide from stomach. // Nature. 1999 Dec 9; 402(6762): Р.656-60.
122. Krieg J.Jr., Santos F., Chan J.C.M. Growth hormone, insulin-like growth factor and the kidney // Kidney Int.-1995.-Vol. 48, № 2.-P. 321-336.
123. Kutner N.G., Zhang R. Body mass index as a predictor of continued survival in older chronic dialysis patients // Int. Urol. Nephrol.-2001.-Vol. 32, № 3.-P. 441-448.
124. Hakim R.M., Levin M. Malnutrition in hemodialysis patients // Am. J. Kidney Dis.-1993.-Vol. 21, № 2.-P. 125-137.
125. Larsson J., Akerlind I., Permerth J., Hornqvist J.-O. The relation between nutritional state and quality of life in surgical patients // Eur. J. Surg.-1994.-Vol. 160, № 6-7.-P. 329-334.
126. Law M.R., Morris J.K., Wald N.J. et al. Serum albumin and mortality in the BUPA study //British United Provident. Assoc. Int. J. Epidemiol.-1994.-Vol. 23, № 1.-P. 38-41.
127. Lesourd B.M., Mazari L. Immune responses during recovery from protein- energy malnutrition // Clin. Nutr.-1997.-Vol. 16, Suppl. 1.-P. 37-46.
128. Louard R.J., Fryburg D.A., Gelfand R.A., Barrett E.J. Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle // J. Clin. Invest.-1992.-Vol. 90.-P. 2348-2354.
129. Louden J.D., Roberts R.R., Goodship T.H.S. Acidosis and nutrition // Kidney Int.-1999.-Vol. 56, Suppl. 73.-P. S-85-S-88.
130. Lowrie EG. Chronic dialysis treatment: clinical outcome and related processes of care// Am J Kidney Dis. 1994 Aug;24(2):255-66.
131. Lowrie E.G., Lew N.L. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities // Am. J. Kidney Dis.-1990.-Vol. 15, №2 5.-P. 458
482.
132. Lowrie E.G., Huang W.H., Lew N.L., Liu Y. The relative contribution of measured variables to death risk among hemodialysis patients // In: Friedman EA (ed). Death on Hemodialysis. Amsterdam: Kluwer Academic.-1994.-P. 121141.
133. Mak R.H., Bettinelli A., Turner C. et al. The influence of hyperparathyroidism on glucose metabolism in uremia // J. Clin. Endocrinol. Metab.-1985.-Vol. 60.- P. 229 - 233.
134. Mak R.H, Cheung W.W. Is ghrelin a biomarker for mortality in end-stage renal disease?// , Kidney Int. 2011 Apr;79(7): Р.697-9.
135. Malatino L.S., Mallamaci F., Benedetto F.A. et al. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end- stage renal disease// Am J Kidney Dis. 2000 Nov;36(5): Р.945-52.
136. Marcen R., Teruel J.L., de la Cal M.A., Gamez C. The impact of malnutrition in morbidity and mortality in stable haemodialysis patients. Spanish Cooperative Study of Nutrition in Hemodialysis// Nephrol Dial Transplant. 1997 Nov;12(11): Р.2324-31.
137. Matsuda K., Nishi Y., Okamatsu Y., Kojima M. et al. Ghrelin and leptin: a link between obesity and allergy // Journal of allergy and clinical Immunology (St Louis MO) 2006; 117 (3): Р.705-706.
138. Mafra D. Are Ghrelin and Leptin Involved in Food Intake and Body Mass Index in Maintenance Hemodialysis // J Renal Nutritoin 2010 May;20(3):P.151- 7.
139. Meier U., Gressner A. Endocrine regulation of Energy Metabolism: Review of Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin, Adiponectin and Resistin. Clinical Chemistry 2004; 50 (9):Р. 1511-1525.
140. Mendez-Sanchez N. Effect of Helicobacter pylori infection in gastric ghrelin expression and body weight // Gastroenterol 2007; 72 (4): Р. 359-364.
141. Misra V., Misra S.P., Shukla S.K. Endoscopic and histological changes in upper gastrointestinal tract of patients with chronic renal failure // Indian J. Pathol Microbiol 2004; 47 (2): Р.170-173.
142. Mitch W.E. Metabolic acidosis stimulates protein metabolism in uremia // Miner. Electrolyte Metab.-1996.-Vol. 2.-P. 62-65.
143. Mitch W.E., Price S.R., May R.S. et al. Metabolic consequences of uremia: extending the concept of adaptive responses to protein metabolism // Am. J. Kidney Dis.-1994.-Vol. 23, № 2.-P. 224-228.
144. Movilli E., Zani R., Carli O., Sangalli L. et al. Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study// Nephrol Dial Transplant. 1998 Jul;13(7): Р.1719-22.
145. Movilli E., Filippini M., Brunori G. et al. Influence of protein catabolic rate on nutritional status, morbidity and mortality in elderly uraemic patients on chronic haemodialysis: a prospective 3-year follow-up study// Nephrol Dial Transplant. 1995;10(4): Р.514-8.
146. Nair K.S., Ford G.C., Ekberg K. et al. Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients // J. Clin. Invest.-1995.-Vol. 95.-P. 2926-2937.
147.Nardone G., Rocco A., Fiorillo M. Helicobarter pylory infection in dyspeptic patients with and without chronic renal failure // Helicobacter 2005; 10 (1): Р. 53-58.
148.Naufel M.F., Bordon M., de Aquino T.M., Ribeiro E.B., de Abreu Carvalhaes Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease. JT Pediatr Nephrol. 2010 Dec;25(12): Р.2477-82.
149.Niebauer J., Clark A.L., Anker S.D., Coats A.J. Three year mortality in heart failure patients with very low left ventricular ejection fractions.// Int J Cardiol. 1999 Aug 31;70(3): Р.24.
150.Nieves M., Sulbaran J., Gaona C. et al. Gastroduodenitis and Helicobacter pylori in uremic patients// G E N. 1992 Apr-Jun;46(2): Р. 113-20.
151.Noori N., Kovesdy C.P., Dukkipati R. et al. Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation// Am J Nephrol. 2011;33(2): Р.157-67.
152.Nordfors L., Lonnqvist F., Heimburger O. et al. Low leptin gene expression and hyperleptinemia in chronic renal failure // Kidney Int.-1998.-Vol. 54.-P. 1267-1275.
153.O’Keefe S.J., Dicker J. Is plasma albumin concentration useful in the assessment of nutritional status of hospital patients? // Eng. J. Clin. Nutr.- 1988.- Vol. 42, № 1.-P. 41-45.
154.Oksa H., Ahonen K., Pasternack A., Marnela K.-M. Malnutrition in hemodialysis patients // Scand. J. Urol. Nephrol.-1991.-Vol. 25, № 2.-P. 157161.
155.Oldrizzi L., Rugiu C., De Biase V. et al. Factors influencing dietary compliance in patients with chronic renal failure on unsupplemented low-protein diet // Cotrib. Nephrol.-1990.-Vol. 81.-P. 9-15.
156. Oner-Iyidogan Y., Gurdol F., Kocak H., Oner P., Cetinalp-Demircan P., Caliskan Y., Kocak T., Turkmen A. Appetite-regulating hormones in chronic kidney disease patients// J Ren Nutr. 2011 Jul;21(4): Р.316-21.
157. Osawa H. Ghrelin and Helicobacter pylori infection // World J Gastroenterol 2008; 14 (41): Р. 6327-6333.
158. Owen W.F., Lew N.L., Liu Y. et al. The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis // N. Eng. J. Med.-1993.-Vol. 329, № 14.-P. 1001-1006.
159. Owen W.F., Lowrie E.G. C-reactive protein as an outcome predictor for maintenance hemodialysis patients // Kidney Int.-1998.-Vol. 54.-P. 627-636.
160. Panzetta G. Protein intake does not depend on the dose of dialysis delivered- -provided Kt/V is adequate.// Nephrol Dial Transplant. 1995 Dec;10(12): Р.2286- 9.
161. Parker T.F., Laird N.M., Lowrie E.G. Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality, and patient withdrawal // Kidney Int.-1983.-Vol. 23, Suppl. 13.-P. 42-49.
162. Pollock C.A., Allen B.J., Warden R.A. et al. Total - body nitrogen by neutron activation in maintenance dialysis // Am. J. Nephrol.-1990.-Vol. 19, №2 1.-P. 3845.
163. Pollock C.A., Ibels L.S., Ayass W. et al. Total body nitrogen as a prognostic marker maintemence dialysis // J. Am. Soc. Nephrol.-1995.-Vol. 16.-P. 82-88.
164. Popovic V. Ghrelin // Current Opinion in Endocrinology @ diabetes 2006; 13: Р.70- 75.
165. Pressman M.R., Benz R.L. Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure // Kidney Int.-1993.-Vol. 43, № 5.-P. 1134-1139.
166. Pupim L. B., Ikizler T. A. Uremic Malnutrition: New Insights Into an Old Problem: Review // Seminars in Dialysis (Cambridge, Ma).-2003.-Vol.16, № 3.-P. 224-232.
167. Rahmati M.A., Craig R.G., Homel P., Kaysen G.A., Levin N.W. Serum markers of periodontal disease status and inflammation in hemodialysis patients// Am J Kidney Dis. 2002 Nov;40(5): Р.983-9.
168. Rasmi Y., Farshid S., Makhdomi K. Effect of duration on hemodialysis on prevalence of Helicobacter pylori infection// Saudi J Kidney Dis Transpl. 2012 May;23(3): Р. 489-92.
169. Reaich D., Channon S.M., Scrimgeour C.M. et al. Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation // Am.
J. Physiol.-1993.-Vol. 265.-P. 230-235.
170. Rocco A., Fiorillo M. Helicobarter pylory infection in dyspeptic patients with and without chronic renal failure // Helicobacter 2005; 10 (1): Р. 53-58.
171. Ross R., Despres J.P. Abdominal obesity, insulin resistance, and the metabolic syndrome: contribution of physical activity/exercise// Obesity (Silver Spring). 2009 Dec;17 Suppl 3: P.S1-2.
172. Rosman J.B., Brandl M., Langer K. Amino acid profiles during prolonged dietary protein restriction // Contrib. Nephrol.-1990.-Vol. 81.-P. 188-193
173. Sanaka T., Shinole M., Audo M. et al. IGF-1 as an early indicator malnutrition in patients with end-stage renal disease // Nephron.-1994.-Vol. 67, № 1.-P. 7381.
174. Sardesai V.M. Fundamentals of nutrition // In: Dekker M (ed) / Introduction to Clinical Nutrition. New York: Sardesai.-1998.-P. 1-13.
175. Sargent J.A., Gotch F.A. Mathematic modeling of dialysis therapy // Kidney Int.-1980.-Vol. 18, № 10.-P. 2-10.
176. Schaefer F., Chen Y., Tsao T. et al. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia // J. Clin. Invest.- 2001.-Vol. 108.-P. 467-475.
177. Schmidt A., Fabrizii V., Maier C. et al . Normal regulation of elevated plasma ghrelin concentrations in dialysis patients // Wien Klin Wochenschr. 2004 Apr 30;116(7-8): Р.235-9.
178. Schofield C., Ashworth A. Why have mortality rates for severe malnutrition remained so high ? // Bull. World Health Organ.-1996.-Vol. 74, № 2.-P. 223229.
179. Scholze A., Tepel M. Role of leptin in reverse epidemiology in chronic kidney disease// Semin Dial. 2007 Nov-Dec;20(6): Р.534-8.
180. Simonian H.P., Kresge K.M., Boden G.H., Parkman H.P. Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferents stimulation mediating ghrelin release // Neorogastroenterol Motil 2005; 17: Р. 348-354.
181. Suneja M., Murry D.J., Stokes J.B., Lim V.S. Hormonal regulation of energy- protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes// Am J Physiol Endocrinol Metab. 2011 Jan;300(1): Р. E55-64.
182. Stenvinkel P., Heimburger O., Paultre F. et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure // Kidney Int.-1999.-Vol. 55.-P. 1899-1911.
183. Stenvinkel P., Heimburger O., Lindholm B. et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation, and atherosclerosis (MIA syndrome) // Nephrol. Dial. Transplant.-2000.-Vol. 15, № 7.-P. 953-960.
184. Suhardjono, Malnutrition-inflammation syndrome in a hemodialysis population: the influence of polymorphic IL-6-174 and IL-10-1082 genes// Acta Med Indones. 2006 Jul-Sep;38(3): Р.145-9.
185. Taylor M.S., Hwang Y., Hsiao P.Y. Ghrelin O-acyltransferase assays and inhibition// Methods Enzymol. 2012;514: Р.205-28.
186. The European Helicobacter pylori Study Group (1997) Current European concepts in the management of Helicobacter pylori infection: The Maastricht Consensus Report. Gut, 41: Р.8-13.
187. Tong J., Prigeon R.L., Davis H.W. et. al. Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans // J Clin Endocrinol Metab. 2013 Jun;98(6): Р. 2536-43.
188. Torun B., Chew F. Protein - energy malnutrition // Modern nutrition in Health and Disease. (8th ed.) / Shils M. E., Olson J. A., Shike M. - Williams and Wilkins.-1994.-P. 950-976.
189. Uribarri J., Protein catabolic rate may underestimate dietary protein intake in hemodialysis patients// Nephron. 1999 Jun;82(2): Р.97-9.
190. Yang Y.J., Sheu B.S., Yang H.B., Lu C.C., Chuang C.C. Eradication of Helicobacter pylori increases childhood growth and serum acylated ghrelin levels // World J Gastroenterol. 2012 Jun 7;18(21):Р.2674-81.
191. Yao Q., Lindholm B., Stenvinkel P. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients // Hemodialysis Int.-2004.-Vol. 8, № 2.-P. 118-129.
192. Young G.A., Swanepoel C.R., Croft M.R. et al. Anthropometry and plasma valine, amimo acids, and proteins in the nutritional assessment of hemodialysis patients // Kidney Int.-1982.-Vol. 21, № 3.-P. 492-499.
193. Yoshimoto A., Mori K., Sugawara A. Plasma ghrelin and desacyl ghrelin concentrations in renal failure//J Am Soc Nephrol. 2002 Nov;13(11):P.2748-52.
194. van der Lely A.J., Tschop M., Heiman M., Ghigo E. Biologycal, physiological, pathophysiological and pharmacological aspects of ghrelin // Endocr Rev 2004; 25:Р. 426-457.
195. Var C., Gultekin F., Candan F. et al. The effects of hemodialysis on duodenal and gastric mucosal changes in uremic patients// Clin Nephrol. 1996 May;45(5):P.310-4.
196. Verdery R.B., Goldberg A.P. Hypocholesterolemia as a predictor of death: A prospective study of 224 nursing home residents // J. Gerontol.-1991.-Vol. 46, № 3.-P. М84-М90.
197. Walser M. Dialysis and protein malnutrition // Kidney Int.-1999.-Vol.56, № 1.-P. 353.
198. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome // Endocr. Rev.-2000.-Vol. 21.-P. 697-738.
199. Wang L., Stengel A., Goebel-Stengel M., Shaikh A., Yuan P.Q., Tache Y.
Intravenous injection of urocortin 1 induces a CRF2 mediated increase in circulating ghrelin and glucose levels through distinct mechanisms in rats// Peptides. 2013 Jan;39: Р.164-70.
200. Wee A., Kang J.Y., Ho M.S. et al., Gastroduodenal mucosa in uraemia: endoscopic and histological correlation and prevalence of helicobacter-like organisms// Gut. 1990 Oct;31(10):Р.1093-6.
201. Wittert G., Chapman I. Physiology of gut hormones an overview // Current Opinion in Endocrinology and Diabetes (Hagerstown, Md) 2006; 13 (1): Р.36-
41.
202. Wolfson M., Strong C.J., Mintum D. et al. Nutritional status and limphocyte function in maintenance hemodialysis patients // Am. J. Clin Nutr.-1984.-Vol. 37, № 4.-P. 547 - 555.
203. Zizzari P., Halem H., Taylor J. et al. Endogenous ghrelin regulates episodic GH secretion by amplifying GH pulse amplitude evidence from antagonism of the GHS-R1a receptor // Endocrinology 2005; 146: Р.3836-3842.